Status:
RECRUITING
A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
Lead Sponsor:
University of Chicago
Conditions:
Hypertension
Blood Pressure
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to test the proof-of-concept for adding a novel mHealth application, USeeBP, to the established UChicago Medicine Ambulatory Medicine Remote-Patient Monitoring (UCM-RPM) H...
Detailed Description
This is a single-arm, proof of concept study, which we will use to assess for initial evidence of efficacy and technical feasibility of adding the USeeBP mHealth app as an adjunct to the UCM-RPM progr...
Eligibility Criteria
Inclusion
- African American
- Ages 18 to 65 years old
- Able to demonstrate English reading literacy of at least 8th grade level \[Rapid Estimate of Adult Literacy in Medicine, Revised (REALM-R) score ≥ 6\]
- Prior hypertension (HTN) diagnosis
- Clinically measured SBP ≥ 160 mmHg recorded during at least 2 of last 4 encounters within past 2 years
- UCM-RPM Hypertension Management Program current or eligible participant
- Access to an Android or Apple iOS smartphone and its corresponding health app
- Access to an active data plan or home Wi-Fi
- Willing to use wireless electronic blood pressure cuff (eCuff)
- Has access to EPIC myChart mobile app or is willing to establish myChart account and download app
- Willing to download USeeBP study app to phone
- Willing to download and use USeeBP app with staff assistance
Exclusion
- Hypertension is managed by a specialist (specialist prescribes the anti-hypertensive therapies)
- Baseline blood pressure greater than 180/110
- Prior enrollment in the study
- Known pregnancy
- Prisoners
- Active opioid dependency
- Homelessness
- Psychiatric hospitalization in the last year
- Serious existing medical conditions that may make BP control difficult or necessitate frequent hospitalization (cirrhosis or hepatic failure, stage IV or V chronic kidney disease, interstitial nephritis, pulmonary arterial hypertension, right heart failure, history of dementia or neurocognitive disability, advanced heart failure, organ transplant, immunosuppressive therapy, active cancer treatment, patients on hospice care), stroke or myocardial infarction in past 90 days, severe aortic stenosis
- Hospital admission for primary diagnosis of hypertensive emergency, hypertensive urgency, or uncontrolled hypertension in the past 90 days
Key Trial Info
Start Date :
October 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06078540
Start Date
October 27 2023
End Date
October 1 2026
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637